Truvex Researchhttps://truvexresearch.comIndependent education on peptide research A New Blood Test for CJC-1295 Shows Why That Compound Is Unusually Easy to Catchhttps://truvexresearch.com/research/cjc-1295-equine-detection-testhttps://truvexresearch.com/research/cjc-1295-equine-detection-testFri, 06 Nov 2026 12:00:00 GMTA racing laboratory has published an assay that detects CJC-1295 in horse plasma at very low concentrations. The reason it works comes down to the modification that makes the molecule last so long. GHRH Plus a GHRP: What Was Actually Tested Together, and What Was Nothttps://truvexresearch.com/research/ghrh-plus-ghrp-what-was-tested-togetherhttps://truvexresearch.com/research/ghrh-plus-ghrp-what-was-tested-togetherFri, 06 Nov 2026 12:00:00 GMTEndocrine studies from the 1990s did test two growth-hormone peptides given at the same time, and found more than the sum of each alone. The pairing discussed online today is not the one they tested. Melanotan: What the 2026 Case Reports Show, and What They Cannot Provehttps://truvexresearch.com/research/melanotan-case-reports-what-clinicians-are-seeinghttps://truvexresearch.com/research/melanotan-case-reports-what-clinicians-are-seeingWed, 04 Nov 2026 12:00:00 GMTDarkened moles, five melanomas in situ, pigmented gums and kidney and muscle injuries: this year's medical literature on unregulated melanotan, read carefully. A New Thymosin Alpha-1 Study Links It to Lower Sepsis Deaths. The Largest Randomised Trial Found No Difference.https://truvexresearch.com/research/thymosin-alpha-1-sepsis-cohort-vs-trialhttps://truvexresearch.com/research/thymosin-alpha-1-sepsis-cohort-vs-trialWed, 04 Nov 2026 12:00:00 GMTA 327-patient hospital records study reports a strong association. A 1,106-patient blinded trial did not. Here is why the two can disagree, and which one carries more weight. GHK-Cu, Explained: What the Copper Peptide Research Measures, and What It Does Nothttps://truvexresearch.com/research/ghk-cu-copper-peptide-research-explainedhttps://truvexresearch.com/research/ghk-cu-copper-peptide-research-explainedTue, 03 Nov 2026 12:00:00 GMTGHK-Cu is three amino acids holding one copper ion. A new dermatology review sorts the cell-culture findings from the human ones, and the gap between them is the story. Four New MOTS-c Papers. Only One Measured People, and It Was a Snapshot.https://truvexresearch.com/research/mots-c-new-papers-one-human-snapshothttps://truvexresearch.com/research/mots-c-new-papers-one-human-snapshotTue, 03 Nov 2026 12:00:00 GMTOctober brought a mouse kidney study, an egg-cell study, a computer model and one small human survey of MOTS-c. Here is what each actually measured, and the controlled trial still running. TB-500 Is Not Thymosin Beta-4. Why the Difference Matters When Reading the Research.https://truvexresearch.com/research/tb-500-is-not-thymosin-beta-4https://truvexresearch.com/research/tb-500-is-not-thymosin-beta-4Fri, 30 Oct 2026 12:00:00 GMTMuch of what is said about TB-500 comes from studies of a different, much larger molecule. A new orthopaedic review spells out the gap, and the product-quality questions that come with it. Two New Reviews Count the Human Evidence for BPC-157. It Comes to 30 People.https://truvexresearch.com/research/bpc-157-human-evidence-two-reviewshttps://truvexresearch.com/research/bpc-157-human-evidence-two-reviewsFri, 30 Oct 2026 12:00:00 GMTA systematic review and an orthopaedic narrative review, both published this month, reach the same finding: decades of animal work, and almost no controlled human data.